Virology News and Research

Latest Virology News and Research

HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

Health and Human Services Secretary Kathleen Sebelius will visit the East Manatee Family Healthcare Center in Bradenton, Fla. on Tuesday, November 10.

10 Nov 2009

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.

10 Nov 2009

AMP's four-day event on the latest advances in clinical molecular diagnostics

The Association for Molecular Pathology (AMP) invites the media to follow its upcoming 2009 Annual Meeting and Exhibits and learn about the latest advances in clinical molecular diagnostics.

10 Nov 2009

Exposure to common infections may increase stroke risk

Cumulative exposure to five common infection-causing pathogens may be associated with an increased risk of stroke, according to a report posted online today that will appear in the January 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.

10 Nov 2009

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.

10 Nov 2009

H1N1 vaccine updates from Pennsylvania Department of Health

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 1,351,400 doses of H1N1 vaccine to Pennsylvania to date, the state Department of Health announced today.

10 Nov 2009

New N95 respirator from Safe Life

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today the availability of the Safe Life A400 Series N95 Respirator with Antimicrobial Protection.

10 Nov 2009

Human movement is a key factor for dengue spread in Brazil

Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases.

10 Nov 2009

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has acquired a portfolio of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called MDT-637.

10 Nov 2009

University of Michigan to develop novel therapy for neuropathic pain

Researchers from the University of Michigan Department of Neurology have received a $1.8 million dollar grant to develop a novel therapy for neuropathic pain, a difficult to treat condition in which patients experience pain because of damage to nerve without obvious tissue injury.

10 Nov 2009

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

The WHO on Friday reported on a rising number of H1N1 (swine flu) cases in China and Japan, Reuters/Washington Post reports. "In China, after an earlier wave of mixed influenza activity (seasonal H3N2 and pandemic H1N1), pandemic H1N1 influenza activity now predominates and is increasing," the agency said. "Sharp increases in pandemic flu infections continue to be reported throughout Japan, particularly on the northern island," the news service writes (Nebehay, 11/6).

10 Nov 2009

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

Humana Military Healthcare Services, a wholly-owned subsidiary of Humana Inc. (NYSE: HUM), encourages TRICARE South Region beneficiaries to get their H1N1 influenza vaccinations in an effort to reduce the spread of the virus. Anticipating a greater need for the shots, the Department of Defense (DoD) is encouraging all military personnel to obtain the vaccines.

9 Nov 2009

NanoViricides to present data on its in vivo studies against influenza

NanoViricides, Inc., announced today that the Company’s CEO, Eugene Seymour, MD, MPH, has been invited to participate in a panel discussion at the Influenza Congress USA 2009, in Washington DC on November 19th (www.terrapinn.com/usaflu). The discussion will center on the “Evolving Role of Anti-Virals” in influenza treatment.

9 Nov 2009

Cellular mechanisms that may impact immune functions in the elderly discovered

Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

San Francisco map of HIV viral loads shows where care lags

Researchers in San Francisco have identified how much virus people infected with HIV are carrying and mapped their results, which show that that AIDS treatment lags in certain neighborhoods. The work also showed that the sickest patients were often African-American, homeless and transgender.

7 Nov 2009

NIH awards UAB School of Public Health $11.5M to research new methods of identifying youth with HIV

The University of Alabama at Birmingham (UAB) School of Public Health has been awarded a total of $11.5 million from the National Institutes of Health to explore new ways to identify adolescents and young adults infected with human immunodeficiency virus (HIV) and link them to medical care.

7 Nov 2009

Health experts report rising number of oral cancer in younger age groups

Mouth cancer (also called oral cancer) is a malignant growth which can occur in any part of the mouth including the lips and tongue. In the UK, the numbers of new cases have risen by over 41 per cent over the last ten years(1).

7 Nov 2009

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.

6 Nov 2009

Gonorrhea medication may help fight cancer

Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.

6 Nov 2009

Virology News and Research

Latest Virology News and Research

HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

AMP's four-day event on the latest advances in clinical molecular diagnostics

Exposure to common infections may increase stroke risk

Study on how robust antibodies work to block the HIV virus raise hope for new vaccine

H1N1 vaccine updates from Pennsylvania Department of Health

New N95 respirator from Safe Life

Human movement is a key factor for dengue spread in Brazil

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

University of Michigan to develop novel therapy for neuropathic pain

H1N1 cases increase in China, Japan; Afghanistan attempts to contain virus

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

NanoViricides to present data on its in vivo studies against influenza

Cellular mechanisms that may impact immune functions in the elderly discovered

San Francisco map of HIV viral loads shows where care lags

NIH awards UAB School of Public Health $11.5M to research new methods of identifying youth with HIV

Health experts report rising number of oral cancer in younger age groups

GeoVax Labs announces financial results and operational update for the third quarter of 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Gonorrhea medication may help fight cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production